FDA rules for R&D also: root cause analysis and failure investigations

Area of Science:

• Medical device development
• Pharmaceutical engineering
• Regulatory affairs

Background:

• Navigating the complex regulatory landscape for medical devices and drug-device combinations is critical for successful product development.
• Understanding specific documentation and methodologies is essential for Research and Development (R&D) scientists and engineers.

Purpose of the Study:

• To discuss successful methodologies and regulatory documentation for medical devices and drug-device combinations.
• To identify and address common regulatory pitfalls throughout the product development lifecycle.
• To share group experiences and insights from R&D, animal testing, clinical testing, and marketing phases.

Main Methods:

• A guided roundtable discussion format.
• Exploration of the medical device and drug-device combination development lifecycle.
• Sharing of group experiences and practical insights.

Main Results:

• Identification of key documentation requirements for various regulatory pathways.
• Discussion on laboratory organization under Good Manufacturing Practices (GMPs) for R&D versus Quality Control (QC).
• Insights into FDA audit experiences within R&D laboratories.

Conclusions:

• Successful medical device and drug-device combination development requires meticulous attention to regulatory documentation and methodologies.
• Proactive identification and mitigation of regulatory pitfalls are crucial for efficient development and marketing.
• Sharing practical experiences and understanding GMP differences between R&D and QC are vital for compliance and successful audits.